Branched‐chain α‐keto‐acid dehydrogenase kinase (BCKDK) has been implicated in promoting RCC metastasis, but its specific substrates and the mechanisms underlying its regulation of RCC progression remain poorly understood. This evidence concerns the gene BCKDK and renal cell carcinoma.